![Corey Goodman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Corey Goodman
Vorsitzender bei
ALX ONCOLOGY HOLDINGS INC.
Vermögen: 318 003 $ am 31.05.2026
Profil
Corey S.
Goodman was the founder of Exelixis, Inc. (1994), Second Genome, Inc. (2009), Labrys Biologics, Inc. (2012) where served as Chairman from 2012 to 2014, Axonis Therapeutics, Inc. (2008) where served as Executive Chairman since 2008, venBio Partners LLC (2009) where served as Managing Partner, Avoro Capital Advisor LLC (2009) where served as Managing Partner, Renovis, Inc. (2001) where served as President, Chief Executive Officer & Director from 2001 to 2007, and Ossianix, Inc. (2011) where served as Chairman.
Dr. Goodman is also the founder of The Helen Wills Neuroscience Institute,Tallac Therapeutics, Inc...- Current jobs include Executive Chairman at ALX Oncology Holdings, Inc. since 2015; Director at Bay Area Science & Innovation Consortium, Emaldi Corp., and Attralus, Inc.; Member of the National Academy of Sciences, American Academy of Arts & Sciences, American Philosophical Society, and The California Council on Science & Technology; Trustee of Goodman Barinaga Trust.
Former jobs include Executive Chairman, President & CEO of Solstice Biologics LLC from 2013 to 2014; Vice Chairman of The Bay Area Bioscience Association; Chairman of The National Research Council, iPierian, Inc., Heart Metabolics Ltd., and Kodiak Sciences, Inc.; Director at Limerick BioPharma, Inc. from 2007 to 2009, Mirna Therapeutics, Inc., NeuroTherapeutics Pharma, Inc., Checkmate Pharmaceuticals, Inc. from 2015 to 2020, and Parabilis Medicines, Inc.; SVP, President-Biotherapeutics & Bioinnovation at Pfizer Inc. from 2007 to 2009; Professor at Stanford University; Member-Supervisory Board at Evotec SE in 2010; Professor at the University of California, Berkeley from 1987 to 2001; Vice President of The McKnight Endowment Fund for Neuroscience.
Education includes undergraduate degree from Stanford University and doctorate from the University of California, Berkeley.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 31.03.2026 | 167’370 ( 0.12% ) | 318 003 $ | 31.05.2026 |
Aktive Positionen von Corey Goodman
| Unternehmen | Position | Beginn |
|---|---|---|
| ALX ONCOLOGY HOLDINGS INC. | Vorsitzender | 01.03.2015 |
Emaldi Corp. | Direktor/Vorstandsmitglied | - |
Goodman Barinaga Trust | Direktor/Vorstandsmitglied | - |
Tallac Therapeutics, Inc.
 Tallac Therapeutics, Inc. BiotechnologyHealth Technology Engages in research and development of immunomodulation polynucleotides | Gründer | - |
Attralus, Inc.
 Attralus, Inc. Pharmaceuticals: MajorHealth Technology Develops novel pan-amyloid removal therapeutics | Direktor/Vorstandsmitglied | - |
Axonis Therapeutics, Inc.
 Axonis Therapeutics, Inc. Medical/Nursing ServicesHealth Services Develops therapies for neurological disorders | Gründer | 01.01.2008 |
venBio Partners LLC
 venBio Partners LLC Investment ManagersFinance venBio invests in companies located in the United States. The firm focuses on companies operating in the fields of life sciences sectors. It participates in early to late stage transactions. The firm acts as a lead investor. | Gründer | 01.06.2009 |
National Academy of Sciences
 National Academy of Sciences Miscellaneous Commercial ServicesCommercial Services Operates as a private, nongovernmental institution that advises on issues related to science and technology | Corporate Officer/Principal | - |
American Academy of Arts & Sciences
 American Academy of Arts & Sciences Miscellaneous Commercial ServicesCommercial Services Operates as organization which honours excellence and convenes leaders | Corporate Officer/Principal | - |
| ░░░░░░░░ ░░░░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Ehemalige bekannte Positionen von Corey Goodman
| Unternehmen | Position | Ende |
|---|---|---|
| ░░░░░░░░░ ░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░░░ ░░░░ | ░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Ausbildung von Corey Goodman
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
91
Beziehungen ersten Grades
35
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 35 |
|---|---|
Pfizer Inc.
 Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Exelixis, Inc.
 Exelixis, Inc. Pharmaceuticals: MajorHealth Technology Operates as a cancer drug discovery company | Health Technology |
Renovis, Inc.
 Renovis, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Solstice Biologics LLC
 Solstice Biologics LLC Pharmaceuticals: MajorHealth Technology Develops cell-permeable RNAi pro-drugs | Health Technology |
Labrys Biologics, Inc.
 Labrys Biologics, Inc. BiotechnologyHealth Technology Provides biotechnology services | Health Technology |
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Evotec SE
 Evotec SE Miscellaneous Commercial ServicesCommercial Services Provides drug discovery and development services | Commercial Services |
University of California, Berkeley
 University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
National Academy of Sciences
National Academy of Sciences Miscellaneous Commercial ServicesCommercial Services Operates as a private, nongovernmental institution that advises on issues related to science and technology | Commercial Services |
American Academy of Arts & Sciences
American Academy of Arts & Sciences Miscellaneous Commercial ServicesCommercial Services Operates as organization which honours excellence and convenes leaders | Commercial Services |
American Philosophical Society
 American Philosophical Society Miscellaneous Commercial ServicesCommercial Services Operates scholarly organization that promotes knowledge in the sciences and humanities | Commercial Services |
The California Council on Science & Technology
 The California Council on Science & Technology Miscellaneous Commercial ServicesCommercial Services Provides objective advice of scientists and research institutions on policy issues involving science | Commercial Services |
The Bay Area Bioscience Association
 The Bay Area Bioscience Association BiotechnologyHealth Technology Provides biomedical communities services | Health Technology |
The McKnight Endowment Fund for Neuroscience
 The McKnight Endowment Fund for Neuroscience Investment Trusts/Mutual FundsMiscellaneous Operates a charitable organization that works to bring science closer to the diseases of the brain and behaviour can be diagnosed, prevented and treated | Miscellaneous |
Limerick BioPharma, Inc.
 Limerick BioPharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs | Health Technology |
The National Research Council
 The National Research Council Miscellaneous Commercial ServicesCommercial Services Provides science, technology and health policy consulting and advice | Commercial Services |
Bay Area Science & Innovation Consortium | |
Mirna Therapeutics, Inc.
 Mirna Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in the development of micro ribonucleic acid based oncology therapeutics | Commercial Services |
NeuroTherapeutics Pharma, Inc.
 NeuroTherapeutics Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical and therapeutic drugs for central nervous system disorders | Health Technology |
venBio Partners LLC
venBio Partners LLC Investment ManagersFinance venBio invests in companies located in the United States. The firm focuses on companies operating in the fields of life sciences sectors. It participates in early to late stage transactions. The firm acts as a lead investor. | Finance |
iPierian, Inc.
 iPierian, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures biopharmaceutical products | Health Technology |
Second Genome, Inc.
 Second Genome, Inc. BiotechnologyHealth Technology Develops microbiome-based therapeutic products | Health Technology |
Avoro Capital Advisor LLC
 Avoro Capital Advisor LLC Investment ManagersFinance AVCAP aims to achieve attractive returns with moderate risk. The firm invests primarily in the equity, debt and associated derivatives of companies operating in the life sciences sector and related industries with a focus on publicly traded, and late-stage private biotechnology companies. | Finance |
Ossianix, Inc.
 Ossianix, Inc. Pharmaceuticals: GenericHealth Technology Develops single domain antibodies | Health Technology |
Heart Metabolics Ltd.
 Heart Metabolics Ltd. BiotechnologyHealth Technology Develops medical therapy for the treatment of heart failure | Health Technology |
The Helen Wills Neuroscience Institute | |
Checkmate Pharmaceuticals, Inc.
 Checkmate Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that develop anti-cancer therapeutics | Health Technology |
Parabilis Medicines
 Parabilis Medicines Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops medicines for cancers and tumors | Health Technology |
Kodiak Sciences, Inc.
 Kodiak Sciences, Inc. BiotechnologyHealth Technology Develops novel therapies for the treatment of retinal disease | Health Technology |
Tallac Therapeutics, Inc.
Tallac Therapeutics, Inc. BiotechnologyHealth Technology Engages in research and development of immunomodulation polynucleotides | Health Technology |
ALX Oncology Holdings, Inc.
 ALX Oncology Holdings, Inc. BiotechnologyHealth Technology Operates as clinical stage immuno-oncology company, which develops therapies for cancer | Health Technology |
Emaldi Corp. | |
Goodman Barinaga Trust | |
Attralus, Inc.
Attralus, Inc. Pharmaceuticals: MajorHealth Technology Develops novel pan-amyloid removal therapeutics | Health Technology |
Axonis Therapeutics, Inc.
Axonis Therapeutics, Inc. Medical/Nursing ServicesHealth Services Develops therapies for neurological disorders | Health Services |
